Treatment of lupus nephritis using laquinimod

This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceuti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NORA TARCIC, ASI HAVIV
Format:	Patent
Sprache:	eng ; heb
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	NORA TARCIC ASI HAVIV
description	This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL250357A0</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL250357A0</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL250357A03</originalsourceid><addsrcrecordid>eNrjZNANKUpNLMlNzStRyE9TyCktKC1WyEstyCjKLMksVigtzsxLV8hJLCzNzMvMzU_hYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxnj5GpgbGpuaOBsaEVQAAVsMp1Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Treatment of lupus nephritis using laquinimod</title><source>esp@cenet</source><creator>NORA TARCIC ; ASI HAVIV</creator><creatorcontrib>NORA TARCIC ; ASI HAVIV</creatorcontrib><description>This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis.</description><language>eng ; heb</language><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170330&DB=EPODOC&CC=IL&NR=250357A0$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170330&DB=EPODOC&CC=IL&NR=250357A0$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NORA TARCIC</creatorcontrib><creatorcontrib>ASI HAVIV</creatorcontrib><title>Treatment of lupus nephritis using laquinimod</title><description>This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNANKUpNLMlNzStRyE9TyCktKC1WyEstyCjKLMksVigtzsxLV8hJLCzNzMvMzU_hYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxnj5GpgbGpuaOBsaEVQAAVsMp1Q</recordid><startdate>20170330</startdate><enddate>20170330</enddate><creator>NORA TARCIC</creator><creator>ASI HAVIV</creator><scope>EVB</scope></search><sort><creationdate>20170330</creationdate><title>Treatment of lupus nephritis using laquinimod</title><author>NORA TARCIC ; ASI HAVIV</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL250357A03</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>NORA TARCIC</creatorcontrib><creatorcontrib>ASI HAVIV</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NORA TARCIC</au><au>ASI HAVIV</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Treatment of lupus nephritis using laquinimod</title><date>2017-03-30</date><risdate>2017</risdate><abstract>This invention provides a method of treating a subject afflicted with active lupus nephritis comprising periodically administering to the subject an amount of laquinimod or pharmaceutically acceptable salt thereof effective to treat the subject. This invention also provides laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis. This invention further provides a pharmaceutical composition comprising an amount of laquinimod or pharmaceutically acceptable salt thereof for use in treating a subject afflicted with active lupus nephritis.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; heb
recordid	cdi_epo_espacenet_IL250357A0
source	esp@cenet
title	Treatment of lupus nephritis using laquinimod
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T02%3A26%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NORA%20TARCIC&rft.date=2017-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL250357A0%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true